Somatostatin (SS), gabexate (GM), or placebo (P) for the prevention of pancreatic damage related to ERCP in patients (pts) at high risk for pancreatitis

✍ Scribed by Andriull, A; Clemente, R; Solmi, L; Perri, F; De Maio, G

• Book ID: 124120960
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 185 KB
• Volume: 120
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(08)81018-9